Current advances in the use of bioluminescence assays for drug discovery: An update of the last ten years
MM Calabretta, E Michelini - Expert Opinion on Drug Discovery, 2024 - Taylor & Francis
Introduction Bioluminescence is a well-established optical detection technique widely used
in several bioanalytical applications, including high-throughput and high-content …
in several bioanalytical applications, including high-throughput and high-content …
[HTML][HTML] Multiplex analysis platform for evaluation of endocrine disruption of emerging contaminants against human steroid hormone receptors using …
Y Huang, W Zhang, R Wang, Z Xiao, JP Giesy… - Emerging …, 2024 - Elsevier
Emerging synthetic or derivative chemicals have drawn global concern due to their potential
endocrine-disrupting effects, either as agonists or antagonists or through indirect effects on …
endocrine-disrupting effects, either as agonists or antagonists or through indirect effects on …
Rapid and reagent-free bioassay using autobioluminescent yeasts to detect agonistic and antagonistic activities of bisphenols against rat androgen receptor and …
Y Huang, W Zhang, C Zhang, N Cui, Z Xiao… - The Journal of Steroid …, 2022 - Elsevier
Bisphenol A (BPA) and its analogues have been classified as endocrine disruptors via
binding to nuclear receptors. Two novel bioassays, BLYrARS and BLYrPRS, were …
binding to nuclear receptors. Two novel bioassays, BLYrARS and BLYrPRS, were …
Complement Biosensors Identify a Classical Pathway Stimulus in Complement-Mediated Hemolytic Uremic Syndrome
MA Cole, N Ranjan, GF Gerber, XZ Pan… - bioRxiv, 2024 - biorxiv.org
Complement-mediated hemolytic uremic syndrome (CM-HUS) is a thrombotic
microangiopathy characterized by germline variants or acquired antibodies to complement …
microangiopathy characterized by germline variants or acquired antibodies to complement …